Rabbit Recombinant Monoclonal CD16a antibody. Carrier free. Suitable for IHC-P, Flow Cyt, WB and reacts with Human samples.
IgG
Rabbit
pH: 7.2 - 7.4
Constituents: PBS
Liquid
Monoclonal
IHC-P | Flow Cyt | WB | |
---|---|---|---|
Human | Tested | Tested | Expected |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes Antigen retrieval: Boil tissue section in EDTA buffer, pH 8.0 for 10 minutes followed by cooling at |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info Use at an assay dependent concentration. | Notes - |
Select an associated product type
Receptor for the Fc region of IgG. Binds complexed or aggregated IgG and also monomeric IgG. Mediates antibody-dependent cellular cytotoxicity (ADCC) and other antibody-dependent responses, such as phagocytosis.
Low affinity immunoglobulin gamma Fc region receptor III-A, CD16a antigen, Fc-gamma RIII-alpha, FcR-10, IgG Fc receptor III-2, Fc-gamma RIII, Fc-gamma RIIIa, FcRIII, FcRIIIa, FCGR3A, FCGR3, FCG3, IGFR3, CD16A
Rabbit Recombinant Monoclonal CD16a antibody. Carrier free. Suitable for IHC-P, Flow Cyt, WB and reacts with Human samples.
IgG
Rabbit
pH: 7.2 - 7.4
Constituents: PBS
Liquid
Monoclonal
Yes
SP189
Affinity purification Protein A/G
Endotoxin level is less than 1 EU/ml as determined by the TAL test
Blue Ice
+4°C
Do Not Freeze
ab246798 is the carrier-free version of Anti-CD16a antibody [SP189] - C-terminal ab227665.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
This product is FOR RESEARCH USE ONLY. For commercial use, please contact partnerships@abcam.com.
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.
This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Our Low endotoxin, azide-free formats have low endotoxin level (1 EU/mg, determined by the TAL assay) and are free from azide, to achieve consistent experimental results in functional assays.
This supplementary information is collated from multiple sources and compiled automatically.
The CD16a protein also known as Fc gamma receptor IIIa (FcγRIIIa) plays an important role in the immune system. This receptor is about 50-70 kDa in mass and is expressed on the surface of natural killer (NK) cells macrophages and some T cells. CD16a facilitates antibody-dependent cellular cytotoxicity (ADCC) by binding to the Fc region of immunoglobulin G (IgG). This interaction allows effector immune cells to recognize and destroy antibody-coated target cells.
CD16a is important for immune responses and occurs as part of a receptor complex. It signals downstream effects through its association with the CD3 zeta chain and the Fc epsilon receptor gamma chain which possess immunoreceptor tyrosine-based activation motifs (ITAMs). Upon binding to IgG CD16a triggers a cascade of events leading to the release of cytokines and cytotoxic granules. This action helps in eliminating infected or cancerous cells demonstrating its role in both innate and adaptive immunity.
CD16a contributes significantly to the immunological synapse formation and NK cell activation pathway. This receptor cooperates with other proteins such as CD3 and CD19 to modulate the immune response. It also participates in signaling pathways like the PI3K-Akt pathway which regulates cell survival and proliferation. CD16a's interaction with these pathways highlights its importance in immune cell communication and function.
CD16a is linked to autoimmune diseases and certain cancers. In autoimmune disorders like systemic lupus erythematosus (SLE) abnormal CD16a function can contribute to the pathogenesis by altering immune cell targeting. Additionally in cancers such as lymphoma CD16a's interaction with IgG-coated cancer cells can influence the efficacy of monoclonal antibody therapies. The receptor's association with proteins like CD3 and CD19 in these disease contexts highlights its potential as a therapeutic target.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Flow cytometric analysis of Jurkat (human T cell leukemia cell line from peripheral blood) cell line labeling CD16a with Anti-CD16a antibody [SP189] - C-terminal ab227665 at 1/100 (green) compared with a rabbit isotype control (blue).
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA and sodium azide (Anti-CD16a antibody [SP189] - C-terminal ab227665).
Formalin-fixed, paraffin-embedded human stomach adenocarcinoma tissue stained for CD16a with Anti-CD16a antibody [SP189] - C-terminal ab227665 at 1/100 dilution in immunohistochemical analysis.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA and sodium azide (Anti-CD16a antibody [SP189] - C-terminal ab227665).
Formalin-fixed, paraffin-embedded human lung tissue stained for CD16a with Anti-CD16a antibody [SP189] - C-terminal ab227665 at 1/100 dilution in immunohistochemical analysis.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA and sodium azide (Anti-CD16a antibody [SP189] - C-terminal ab227665).
Formalin-fixed, paraffin-embedded human liver tissue stained for CD16a with Anti-CD16a antibody [SP189] - C-terminal ab227665 at 1/100 dilution in immunohistochemical analysis.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA and sodium azide (Anti-CD16a antibody [SP189] - C-terminal ab227665).
Formalin-fixed, paraffin-embedded human thymus tissue stained for CD16a with Anti-CD16a antibody [SP189] - C-terminal ab227665 at 1/100 dilution in immunohistochemical analysis.
Formalin-fixed, paraffin-embedded human liver hepatocellular carcinoma tissue stained for CD16a with Anti-CD16a antibody [SP189] - C-terminal ab227665 at 1/100 dilution in immunohistochemical analysis.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA and sodium azide (Anti-CD16a antibody [SP189] - C-terminal ab227665).
Formalin-fixed, paraffin-embedded human placenta tissue stained for CD16a with Anti-CD16a antibody [SP189] - C-terminal ab227665 at 1/100 dilution in immunohistochemical analysis.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA and sodium azide (Anti-CD16a antibody [SP189] - C-terminal ab227665).
Formalin-fixed, paraffin-embedded human B-cell lymphoma tissue stained for CD16a with Anti-CD16a antibody [SP189] - C-terminal ab227665 at 1/100 dilution in immunohistochemical analysis.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA and sodium azide (Anti-CD16a antibody [SP189] - C-terminal ab227665).
Formalin-fixed, paraffin-embedded human cervical squamous cell carcinoma tissue stained for CD16a with Anti-CD16a antibody [SP189] - C-terminal ab227665 at 1/100 dilution in immunohistochemical analysis.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA and sodium azide (Anti-CD16a antibody [SP189] - C-terminal ab227665).
Formalin-fixed, paraffin-embedded human colon adenocarcinoma tissue stained for CD16a with Anti-CD16a antibody [SP189] - C-terminal ab227665 at 1/100 dilution in immunohistochemical analysis.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA and sodium azide (Anti-CD16a antibody [SP189] - C-terminal ab227665).
Formalin-fixed, paraffin-embedded human HK lymphoma tissue stained for CD16a with Anti-CD16a antibody [SP189] - C-terminal ab227665 at 1/100 dilution in immunohistochemical analysis.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA and sodium azide (Anti-CD16a antibody [SP189] - C-terminal ab227665).
Formalin-fixed, paraffin-embedded human spleen tissue stained for CD16a with Anti-CD16a antibody [SP189] - C-terminal ab227665 at 1/100 dilution in immunohistochemical analysis.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA and sodium azide (Anti-CD16a antibody [SP189] - C-terminal ab227665).
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com